Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-12-06

Clinical Trial Update: Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.

View source ↗

Summary

A terminated clinical trial update evaluating hypoglycemia- and weight-related quality of life in patients with type 2 diabetes treated with sulfonylurea deriva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus Type 2 | Status: TERMINATED